Cargando…
The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients
BACKGROUND: Sepsis complication is a major cause of death in multiple trauma critically ill patients. Defensin (cysteine rich anti-microbial peptides), as an important component of immune system, might play an important role in this process. There is also rising data on immunological effects of N-ac...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223415/ https://www.ncbi.nlm.nih.gov/pubmed/25027749 http://dx.doi.org/10.1186/2008-2231-22-57 |
_version_ | 1782343194072055808 |
---|---|
author | Najafi, Atabak Mojtahedzadeh, Mojtaba Ahmadi, Keyvan Haji Abdollahi, Mohammad Mousavi, Maryam Chelkeba, Legese Najmeddin, Farhad Ahmadi, Arezoo |
author_facet | Najafi, Atabak Mojtahedzadeh, Mojtaba Ahmadi, Keyvan Haji Abdollahi, Mohammad Mousavi, Maryam Chelkeba, Legese Najmeddin, Farhad Ahmadi, Arezoo |
author_sort | Najafi, Atabak |
collection | PubMed |
description | BACKGROUND: Sepsis complication is a major cause of death in multiple trauma critically ill patients. Defensin (cysteine rich anti-microbial peptides), as an important component of immune system, might play an important role in this process. There is also rising data on immunological effects of N-acetyl-cysteine (NAC), a commonly used anti-oxidant in oxidative stress conditions and glutathione (GSH) deficiencies. The aim of the present study was to evaluate the potential beneficial effects of NAC administration on multiple trauma patients with sepsis. METHODS: In a prospective, randomized controlled study, 44 multiple trauma critically ill patients who were mechanically ventilated and met the criteria of sepsis and admitted to the intensive care unit (ICU) were randomized into two groups . Control group received all standard ICU therapies and NAC group received intravenous NAC 3 gr every 6 hours for 72 hours in addition to standard therapies. Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores, length of ICU stay, ICU mortality were recorded. Levels of serum Immunoglobulin M (IgM), Human β-Defensin 2 (HβD2) and GSH were assessed at baseline and 24, 72, 120 hours after intervention. RESULTS: During a period of 13-month screening, 44 patients underwent randomization but 5 patients had to be excluded. 21 patients in NAC group and 18 patients in control group completed the study. For both groups the length of ICU stay, SOFA score and systemic oxygenation were similar. Mortality rate (40% vs. 22% respectively, p = 0.209) and ventilator days (Mean ± SD 19.82 ± 19.55 days vs. 13.82 ± 11.89 days respectively, p = 0.266) were slightly higher for NAC group. IgM and GSH levels were similar between two groups (p = 0.325, 0.125 respectively), HβD2 levels were higher for NAC group (at day 3). CONCLUSION: High dose of NAC administration not only did not improve patients’ outcome, but also raised the risk of inflammation and was associated with increased serum creatinine. |
format | Online Article Text |
id | pubmed-4223415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42234152014-11-08 The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients Najafi, Atabak Mojtahedzadeh, Mojtaba Ahmadi, Keyvan Haji Abdollahi, Mohammad Mousavi, Maryam Chelkeba, Legese Najmeddin, Farhad Ahmadi, Arezoo Daru Research Article BACKGROUND: Sepsis complication is a major cause of death in multiple trauma critically ill patients. Defensin (cysteine rich anti-microbial peptides), as an important component of immune system, might play an important role in this process. There is also rising data on immunological effects of N-acetyl-cysteine (NAC), a commonly used anti-oxidant in oxidative stress conditions and glutathione (GSH) deficiencies. The aim of the present study was to evaluate the potential beneficial effects of NAC administration on multiple trauma patients with sepsis. METHODS: In a prospective, randomized controlled study, 44 multiple trauma critically ill patients who were mechanically ventilated and met the criteria of sepsis and admitted to the intensive care unit (ICU) were randomized into two groups . Control group received all standard ICU therapies and NAC group received intravenous NAC 3 gr every 6 hours for 72 hours in addition to standard therapies. Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores, length of ICU stay, ICU mortality were recorded. Levels of serum Immunoglobulin M (IgM), Human β-Defensin 2 (HβD2) and GSH were assessed at baseline and 24, 72, 120 hours after intervention. RESULTS: During a period of 13-month screening, 44 patients underwent randomization but 5 patients had to be excluded. 21 patients in NAC group and 18 patients in control group completed the study. For both groups the length of ICU stay, SOFA score and systemic oxygenation were similar. Mortality rate (40% vs. 22% respectively, p = 0.209) and ventilator days (Mean ± SD 19.82 ± 19.55 days vs. 13.82 ± 11.89 days respectively, p = 0.266) were slightly higher for NAC group. IgM and GSH levels were similar between two groups (p = 0.325, 0.125 respectively), HβD2 levels were higher for NAC group (at day 3). CONCLUSION: High dose of NAC administration not only did not improve patients’ outcome, but also raised the risk of inflammation and was associated with increased serum creatinine. BioMed Central 2014-07-15 /pmc/articles/PMC4223415/ /pubmed/25027749 http://dx.doi.org/10.1186/2008-2231-22-57 Text en Copyright © 2014 Mojtahedzadeh et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Najafi, Atabak Mojtahedzadeh, Mojtaba Ahmadi, Keyvan Haji Abdollahi, Mohammad Mousavi, Maryam Chelkeba, Legese Najmeddin, Farhad Ahmadi, Arezoo The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients |
title | The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients |
title_full | The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients |
title_fullStr | The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients |
title_full_unstemmed | The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients |
title_short | The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients |
title_sort | immunological benefit of higher dose n-acetyl cysteine following mechanical ventilation in critically ill patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223415/ https://www.ncbi.nlm.nih.gov/pubmed/25027749 http://dx.doi.org/10.1186/2008-2231-22-57 |
work_keys_str_mv | AT najafiatabak theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT mojtahedzadehmojtaba theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT ahmadikeyvanhaji theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT abdollahimohammad theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT mousavimaryam theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT chelkebalegese theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT najmeddinfarhad theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT ahmadiarezoo theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT najafiatabak immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT mojtahedzadehmojtaba immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT ahmadikeyvanhaji immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT abdollahimohammad immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT mousavimaryam immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT chelkebalegese immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT najmeddinfarhad immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients AT ahmadiarezoo immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients |